Preclinical Study on Alleviating Pancreatic Oxidative Stress and Safety of Novel Anti-Hyperglycemic Polyherbal Formulation
Natural and Life Sciences Communications · 12.06.2026 · 25 (4)
DOI: 10.12982/nlsc.2026.075 ↗Kurz gefasst
Fachartikel in der Zeitschrift Natural and Life Sciences Communications, online erschienen am 12.06.2026. Verfasst von Tran Huyen Tran und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Although Moringa oleifera, Vernonia amygdalina, and Centella asiatica are prominent tropical medicinal plants with various biological activities, the potential to allevate pancreatic oxidative stress and safety profile of a novel polyherbal formulation containing their leaf extracts have not been established. Therefore, this study was designed to evaluate the improvement in pancreatic oxidative stress and preclinical safety of this formulation. The pharmacological effects were evaluated in a streptozotocin-induced hyperglycemic mouse model. Preclinical safety was assessed according to OECD guidelines 423 (acute toxicity) and 407 (subchronic toxicity). After 7 days of treatment, the formulation (400 mg/kg) exhibited significant hypoglycemic activity. It also protected the pancreas against streptozotocin-induced oxidative stress by decreasing malondialdehyde (MDA) levels and increasing glutathione (GSH) concentrations in pancreatic tissue. In terms of safety, the formulation showed no acute toxicity, with an LD50 value greater than 5,000 mg/kg. During the 56-day subchronic toxicity study, the formulation (at 400 and 800 mg/kg) caused no mortality or significant changes in behavior and body weight. However, it did alter some biochemical, hematological, and histopathological parameters. Taken together, these findings suggest that the polyherbal formulation of M. oleifera, V. amygdalina, and C. asiatica extracts is a promising candidate for further development as a novel anti-hyperglycemic agent, although careful monitoring of its long-term effects is warranted.
Zitieren
APA
Tran, T. H., Le, U. V., Nguyen, H. T. T., & Ly, T. H. (2026). Preclinical Study on Alleviating Pancreatic Oxidative Stress and Safety of Novel Anti-Hyperglycemic Polyherbal Formulation. Natural and Life Sciences Communications, 25(4). https://doi.org/10.12982/nlsc.2026.075
Vancouver
Tran TH, Le UV, Nguyen HTT, Ly TH. Preclinical Study on Alleviating Pancreatic Oxidative Stress and Safety of Novel Anti-Hyperglycemic Polyherbal Formulation. Natural and Life Sciences Communications. 2026;25(4). doi:10.12982/nlsc.2026.075
BibTeX
@article{Tran2026,
author = {Tran, Tran Huyen and Le, Ut Van and Nguyen, Huong Thu Thi and Ly, Trieu Hai},
title = {Preclinical Study on Alleviating Pancreatic Oxidative Stress and Safety of Novel Anti-Hyperglycemic Polyherbal Formulation},
journal = {Natural and Life Sciences Communications},
year = {2026},
volume = {25},
number = {4},
doi = {10.12982/nlsc.2026.075}
}
EUVIMED